21173 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus inactivated (killed)
Inactivated FCV vaccines
#902Novel vaccine
#903Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#904Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#905Immunogenic compositions
#906Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
#907Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
#908Purification of HBV antigens for use in vaccines
#909Circovirus sequences associated with piglet weight loss disease (PWD)
#910Inactivated bovine herpes virus-1 and methods
#911Influenza Virus Vaccine
#912Alphavirus Vectors for Respiratory Pathogen Vaccines
#913Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#914Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#915Circovirus sequences associated with piglet weight loss disease (PWD)
#916Virosome particles comprising antigens from influenza virus and hepatitis b virus
#917Methods for drying a viral vaccine
#918Method for producing the flu virus
#919Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#920Dry Formulation for Transcutaneous Immunization
#921Immunogenic compositions and methods
#922Tissue targeted antigenic activation of the immune response to cancers
#923Yeast-based therapeutic for chronic hepatitis C infection
#924COMPOSITIONS AND METHODS FOR ORTHOPOX VIRUS VACCINATION
#925Canine influenza virus and related compositions and methods of use
#926Novel use
#927Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases
#928Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
#929Enhancement of immune response to vaccine by interferon alpha
#930SARS Vaccine Compositions and Methods of Making and Using Them
#931Vaccines against West Nile Virus
#932Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
#933Raccoon poxvirus expressing rabies glycoproteins
#934Prevention and treatment of sub-clinical PCVD
#935Method for inactivating viruses with slightly acidic arginine
#936VIRAL VACCINE AND METHOD FOR PREPARATION THEREOF
#937Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor
#938DNA-transfection system for the generation of infectious influenza virus
#939DNA-transfection system for the generation of infectious influenza virus
#940Highly Attenuated Pox Virus Strains, Method for the Production Thereof and the Use Thereof as Paramunity Inducers or For Producing Vector Vaccines
#941Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
#942Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods
#943Two-step temperature profile for the propagation of viruses
#944Viral adjuvants
#945USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#946Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#947Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#948Disease Prevention and Vaccination Prior to Thymic Reactivation
#949ANIMAL CELLS AND PROCESSES FOR THE REPLICATION OF INFLUENZA VIRUSES
#950Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases
#951USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#952Monoparamunity inducers based on attenuated rabbit myxomaviruses
#953Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#954PROTEOSOME INFLUENZA VACCINE
#955Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#956Vaccines and methods to treat canine influenza
#957Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
#958CANINE INFLUENZA VACCINES
#959DNA-transfection system for the generation of infectious influenza virus
#960Circovirus sequences associated with piglet weight loss disease (PWD)
#961Multivalent avian influenza vaccines and methods
#962Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#963Mutated heat-labile enterotoxin
#964Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties
#965Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties
#966Monoparamunity inducers based on attenuated rabbit myxomaviruses
#967Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
#968Vaccines against West Nile Virus
#969Vaccine
#970Sustained release vaccine composition
#971Infectious Bursal Disease Virus antigenic isolates and vaccines
#972Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus
#973Vaccine formulations
#974Immunstimulating lipid formulation
#975NOVEL VACCINE COMPOSITION
#976USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
#977Vaccine
#978Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same
#979Multi-subtype FIV vaccines
#980Avian influenza viruses, vaccines, compositions, formulations, and methods
#981Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
#982Virulent systemic feline calicivirus
#983FELINE VACCINES AGAINST AVIAN INFLUENZA
#984Feline vaccines against avian influenza
#985Yeast-based therapeutic for chronic hepatitis C infection
#986Feline influenza vaccine and method of use
#987Mutated heat-labile enterotoxin
#988Apparatus for vaccine development using ultrasound technology
#989Composition comprising iscom particles and live micro-organisms
#990Immunological combination compositions and methods
#991Materials and methods for respiratory disease control in canines
#992VACCINE COMPOSITION
#993Yeast-based therapeutic for chronic hepatitis C infection
#994Influenza Hemagglutinin And Neuraminidase Variants
#995Hemorrhagic feline calicivirus
#996Pharmaceutical Anti-Herpetic Composition, Method for Producing a Dosage Form Based Thereon and Method for the Use Thereof
#997Influenza hemagglutinin and neuraminidase variants
#998Compositions and methods for orthopox virus vaccination
#999Production of HIV
#1000Method for Amplifying Therapeutic Vaccine Activity
#1001Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1002Method of immunization against the 4 dengue serotypes
#1003INFLUENZA VACCINE
#1004Mutant cells with altered sialic acid
#1005Cattle reproductive disease vaccines
#1006RNA virus vaccines and methods
#1007Vaccine and Method of Use
#1008Canine influenza virus
#1009Immunogenic Hiv Compositions and Related Methods
#1010Circovirus sequences associated with piglet weight loss disease (PWD)
#1011Purification processes for isolating purified vesicular stomatitis virus from cell culture
#1012Non-live trivalent influenza vaccine for one-dose intradermal delivery
#1013West Nile vaccine
#1014West nile DNA vaccine
#1015Apparatus and methods for vaccine development using ultrasound technology
#1016dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
#1017Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity
#1018Preparation of Vaccines Using Photosensitizers and Light
#1019Method of treating and preventing infectious diseases
#1020Use of vaccines for the treatment/prevention of the transmission of pathogens
#1021Equine herpesvirus vaccine
#1022Methods for preventing or ameliorating West Nile encephalitis
#1023Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine
#1024West Nile vaccine
#1025West Nile vaccine
#1026West Nile vaccine
#1027Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
#1028Polyinosinic acid-polycytidylic acid-based adjuvant
#1029Modified vaccinia virus Ankara (MVA) mutant and use thereof
#1030Paramunity inducers based on attenuated rabbit myxoma virus
#1031Enveloped virus vaccine and method for production
#1032Influenza vaccine
#1033Novel plant virus particles and methods of inactivation thereof
#1034Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
#1035Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
#1036Circovirus sequences associated with piglet weight loss disease (PWD)
#1037Canine influenza virus and related compositions and methods of use
#1038Compositions and methods for the treatment of canine influenza virus disease
#1039Attenuated dengue virus comprising mutations in the NS3 gene
#1040Interleukin-12 as an adjuvant for paramyxoviridae vaccines
#1041Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
#1042Vaccines and methods to treat canine influenza
#1043Methods for testing vaccine candidates against bacterial infection in rodents
#1044Circovirus sequences associated with piglet weight loss disease (PWD)
#1045Circovirus sequences associated with piglet weight loss disease (PWD)
#1046Preparation of vaccines using a photosensitizer and light
#1047Circovirus sequences associated with piglet weight loss disease (PWD)
#1048Circovirus sequences associated with piglet weight loss disease (PWD)
#1049Canine influenza vaccines
#1050Circovirus sequences associated with piglet weight loss disease (PWD)
#1051Circovirus sequences associated with piglet weight loss disease (PWD)
#1052Circovirus sequences associated with piglet weight loss disease (PWD)
#1053Compositions and methods to treat and control tumors by loading antigen presenting cells
#1054Method of making modified immunodeficiency virus particles
#1055Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#1056Inactivating pathogens with oxidizing agents for vaccine production
#1057Immunstimulating lipid formulation
#1058Inactivated chimeric flavivirus
#1059Method and device for transdermal immunization
#1060Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseases
#1061Rabies vaccine
#1062Severe acute respiratory syndrome coronavirus
#1063Inactivated nodavirus vaccine
#1064Carrier of a diamond fine particle for immobilizing virus
#1065Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
#1066Prevention of type 1 diabetes and other non-polio enterovirus diseases
#1067Induction of mucosal immunity by vaccination via the skin route
#1068Circovirus sequences associated with piglet weight loss disease (PWD)
#1069Circovirus sequences associated with piglet weight loss disease (PWD)
#1070Mutants of replication competent vaccinia virus
#1071Multivalent avian influenza vaccines
#1072Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
#1073Delivery vehicles, bioactive substances and viral vaccines
#1074Recombinant influenza vectors with tandem transcription units
#1075Inactivated FCV vaccines
#1076Purification of HBV antigens for use in vaccines
#1077Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
#1078H3 equine influenza A virus
#1079Trivalent vaccine with maternal anitbody transfer via the milk
#1080Methods for inducing an immune response via oral administration of an adenovirus
#1081Oral drug delivery compositions and methods
#1082Herpes viruses for immune modulation
#1083Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
#1084Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines
#1085Porcine reproductive and respiratory syndrome virus receptor components and uses thereof
#1086Yeast-based therapeutic for chronic hepatitis C infection
#1087Immunological combination compositions and methods
#1088Circovirus sequences associated with piglet weight loss disease (PWD)
#1089Production of vaccines
#1090Novel vaccine
#1091Production of vaccines
#1092Intradermal delivery of vacccines and therapeutic agents
#1093Immunizing fish against viral infection
#1094Method and device for detecting feline immunodeficiency virus
#1095Method and device for detecting feline immunodeficiency virus
#1096Transcutaneous immunization without heterologous adjuvant
#1097Vaccine comprising an attenuated pestivirus
#1098Methods of use of viral vectors to deliver antigen to dendritic cells
#1099Feed for fish and shellfish, additive therefor, and method for producing additive
#1100Inactivated bovine scours vaccines, process and method of preventing bovine scours
#1101Recombinant lentivirus encoding modified GP 120 signal sequences
#1102Cellular permissivity factor for viruses and uses thereof
#1103Infectious bursal disease virus antigenic isolates and vaccines
#1104Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
#1105Antitumor agents with the use of HSV
#1106Circovirus sequences associated with piglet weight loss disease (PWD)
#1107Family of picornaviruses
#1108Process for making an adjuvanted vaccine comprising host albumin
#1109Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs
#1110Method to enhance an immune response of nucleic acid vaccination
#1111Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
#1112Immunogenic composition and method of developing a vaccine based on fusion protein
#1113Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
#1114Methods of characterizing infectious bursal disease virus
#1115Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
#1116Vaccine against feline calicivirus
#1117Animal cells and processes for the replication of influenza viruses
#1118Intranasal influenza virus vaccine
#1119Immunogenic HIV compositions and related methods
#1120DNA transfection system for the generation of infectious influenza virus
#1121Vaccines against West Nile Virus
#1122IHNV G protein for immune stimulation
#1123Oral vaccine, method for its preparation and use thereof
#1124Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture
#1125Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof
#1126Hepatitis A vaccines
#1127Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
#1128Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
#1129Immunogenic composition and method of developing a vaccine based on factor H binding sites
#1130Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
#1131Feed for fish and shellfish, additive therefor, and method for producing additive
#1132Equine herpesvirus vaccine
#1133Circovirus sequences associated with piglet weight loss disease (PWD)
#1134Vaccine formulations
#1135Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains
#1136Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits
#1137Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
#1138Modified viral particles with immunogenic properties and reduced lipid content
#1139Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#1140Circovirus sequences associated with piglet weight loss disease (PWD)
#1141Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms
#1142Coronavirus disease (COVID-19) vaccine
#1143Nucleic acid-based adjuvant and porcine vaccine composition including the same